Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
15
RXRX Quote, Financials, Valuation and Earnings
Last price:
$4.41
Seasonality move
:
-16.61%
Day range:
$4.30 - $4.43
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
40.00x
P/B ratio:
2.17x
Volume:
26M
Avg. volume:
24.2M
1-year change:
-39.23%
Market cap:
$2.3B
Revenue:
$58.8M
EPS (TTM):
-$1.81
Earnings Data
Next earnings date for RXRX
Feb 26
2026
Most recent earnings per share
-$0.36
Beat by $0.02
(Nov 5/2025)
Consensus Estimate
-$0.38
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $24.6M | -- | -- | -$0.32 | -- |
| 11/05/2025 | Q3 | $19.4M | $5.2M | -$0.36 | -$0.38 | $0.02 |
| 08/05/2025 | Q2 | $15.4M | $19.2M | -$0.41 | -$0.35 | -$0.06 |
| 05/08/2025 | Q1 | $18.1M | $14.7M | -$0.50 | -$0.52 | $0.01 |
| 02/28/2025 | Q4 | $19M | $4.5M | -$0.53 | -$0.42 | -$0.12 |
| 11/06/2024 | Q3 | $29.8M | $26.1M | -$0.34 | -$0.33 | -$0.01 |
| 08/08/2024 | Q2 | $13.3M | $14.4M | -$0.40 | -$0.38 | -$0.02 |
| 05/09/2024 | Q1 | $13.1M | $13.5M | -$0.39 | -$0.43 | $0.04 |
| 02/27/2024 | Q4 | $20.4M | $10.6M | -$0.42 | -$0.45 | $0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/08/2023 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/08/2023 | Q1 | -- | -- | -$0.34 | -$0.35 | $0.01 |
| 02/27/2023 | Q4 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.35 | -$0.38 | $0.03 |
| 08/09/2022 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | -$0.33 | $0.51 | -$0.84 |
| 03/23/2022 | Q4 | -- | -- | -$0.38 | -$0.31 | -$0.07 |
| 11/10/2021 | Q3 | -- | -- | -$0.28 | -$0.28 | $0.00 |
| 08/13/2021 | Q2 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -$0.23 | $0.04 |
| 12/31/2020 | Q4 | -- | -- | -$0.23 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Recursion Pharmaceuticals, Inc. Earnings Questions
-
How Much did Recursion Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Recursion Pharmaceuticals, Inc. reported $5.2M worth of top line sales in its most recent quarter.
-
Did Recursion Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Recursion Pharmaceuticals, Inc. announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.38 per share.
-
Is Recursion Pharmaceuticals, Inc. Profitable?
Recursion Pharmaceuticals, Inc. reported -$22.9M that represents -$0.05 per share over the last quarter.
-
What is the Analyst Consensus for Recursion Pharmaceuticals, Inc. EPS Next Year?
Recursion Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.69 per share to -$1.54 per share next year representing a decrease of -4.92%.
-
When is Recursion Pharmaceuticals, Inc.'s Earnings Date?
Recursion Pharmaceuticals, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
